1,085
Participants
Start Date
June 30, 2009
Primary Completion Date
March 31, 2012
Study Completion Date
March 31, 2012
Risperidone Long-Acting injectable or oral antipsychotics
According to label
Brno
České Budějovice
Most
Olomouc
Prague
Přerov
Bar-le-Duc
Boulogne-Billancourt
Bourg-en-Bresse
Challans
Créteil
Dax
La Roche-sur-Yon
La Seyne-sur-Mer
Laxou
Marseille
Mont-Saint-Martin
Montpellier
Morlaix
Plouguernével
Rennes
Saint-Avé
Saint-Égrève
Sarreguemines
Verdun
Villejuif
Augsburg
Bad Honnef
Berlin
Bochum
Butzbach
Chemnitz
Coesfeld
Cologne
Dortmund
Dresden
Düsseldorf
Ebensfeld
Frankfurt
Fürth
Geithain
Greifswald
Grevenbroich
Hamburg
Ilmenau
Köthen
Krefeld
Leipzig
Limburg
Löhne
Magdeburg
Mannheim
München
Neuss
Oranienburg
Plauen
Potsdam
Riesa
Schleswig
Stolberg
Stralsund
Ulm
Velbert
Wetzlar
Wismar
Wuppertal
Arta
Athens
Chania
Crete
Ioannina
Larissa
Thessalonikis
Véroia
Kronshtadt
Nizhny Novgorod
Saint Petersburg
Yekaterinburg
Birmingham
Pretoria
A Coruña
Burgos
Getafe
Madrid
Monforte de Lemos
Salamanca
Valladolid
Vigo
Adana
Ankara
Erzurum
Eskişehir
Istanbul
Izmir
Kocaeli
Manisa
Mersin
Trabzon
Lead Sponsor
Janssen-Cilag International NV
INDUSTRY